Two-dimensional in vivo rectal dosimetry during high-dose-rate brachytherapy for cervical cancer: a phantom study.

CONCLUSIONS: The 2D in vivo rectal dosimetry using the ERB with EBT3 films was effective and might be clinically applicable for HDR brachytherapy for cervical and prostate cancers to monitor treatment accuracy and consistency as well as to predict rectal toxicity.
PMID: 30004264 [PubMed - as supplied by publisher]

Source: Acta Oncologica - July 13, 2018 Category: Cancer & Oncology Authors: Jeang EH, Goh Y, Cho KH, Min S, Choi SH, Jeong H, Jo K, Lee N, Song S, Lee SB, Shin D, Kim YJ, Kim JY, Kim DY, Hwang UJ, Lim YK Tags: Acta Oncol Source Type: research